MNBTD
UTHR icon

Moody National Bank Trust Division’s United Therapeutics UTHR Stock Holding History

Moody National Bank Trust Division’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Buy
2,170
+7
+0.3% +$3.94K 0.1% 209
2026
Q1 		$1.28M Buy
2,163
+23
+1% +$11.5K 0.12% 158
2025
Q4 		$1.04M Sell
2,140
-1,248
-37% -$581K 0.1% 208
2025
Q3 		$1.42M Sell
3,388
-81
-2% -$27.2K 0.12% 180
2025
Q2 		$997K Buy
3,469
+77
+2% +$23K 0.09% 240
2025
Q1 		$1.05M Buy
3,392
+11
+0.3% +$3.77K 0.11% 221
2024
Q4 		$1.19M Sell
3,381
-207
-6% -$76.1K 0.12% 190
2024
Q3 		$1.29M Buy
3,588
+97
+3% +$32.8K 0.14% 174
2024
Q2 		$1.11M Buy
3,491
+30
+0.9% +$7.94K 0.09% 169
2024
Q1 		$795K Buy
3,461
+39
+1% +$8.8K 0.06% 232
2023
Q4 		$752K Buy
+3,422
New +$789K 0.06% 251

Other funds holding UTHR

AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Moody National Bank Trust Division's UTHR Position: Q2 2026 in Review

Moody National Bank Trust Division increased its United Therapeutics (UTHR) stake by 0.32% in Q2 2026, buying an estimated $3.94K and bringing the position to 2,170 shares worth $1.18M. The position accounts for 0.1% of the portfolio, ranked #209.

Moody National Bank Trust Division first reported a position in UTHR in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.42M in Q3 2025. 281 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Moody National Bank Trust Division held 2,170 shares of United Therapeutics worth $1.18M as of Q2 2026.
  • Moody National Bank Trust Division bought 7 United Therapeutics shares in Q2 2026, an estimated $3.94K.
  • United Therapeutics made up 0.1% of Moody National Bank Trust Division's portfolio in Q2 2026, its #209 holding.
  • Moody National Bank Trust Division first reported a position in United Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • Moody National Bank Trust Division's United Therapeutics position peaked at $1.42M in Q3 2025.
  • 281 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Moody National Bank Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.